Congenital diseases caused by defective

Area of Science:

• Developmental Biology
• Cellular Signaling
• Glycobiology

Background:

• The Notch signaling pathway is vital for animal development, regulating cell differentiation, survival, and proliferation.
• Notch receptors interact with ligands via epidermal growth factor-like (EGF) repeats, which are frequently modified by O-glycosylation.
• O-glycan modifications, including O-linked N-acetylglucosamine (O-GlcNAc) and O-fucose, are crucial for Notch receptor function and cell surface stability.

Purpose of the Study:

• To review the role of O-glycosylation in Notch receptor function.
• To discuss congenital human diseases associated with defects in Notch receptor O-glycosylation.
• To highlight the importance of O-glycans in Notch-ligand interactions and signaling.

Main Methods:

• Literature review of Notch signaling and glycosylation.
• Analysis of genetic mutations affecting Notch receptors and glycosyltransferases.
• Discussion of the functional impact of O-glycan defects on Notch pathway regulation.

Main Results:

• O-fucose is essential for Notch receptor-ligand binding.
• Mutations in EOGT (EGF domain-specific O-GlcNAc transferase) and NOTCH1 are linked to Adams-Oliver syndrome.
• Defects in Notch O-glycosylation disrupt receptor trafficking, cell surface stability, and ligand interaction.

Conclusions:

• O-glycosylation is a critical regulatory mechanism for Notch signaling.
• Aberrant O-glycosylation of Notch receptors leads to various congenital disorders.
• Further research into O-glycan roles is necessary for understanding Notch-related diseases.